Study of Metastatic Ocular Melanoma

Status Recruiting

Clinical Trial Summary

This study evaluates treatment with combination versus monotherapy for patients with metastatic ocular melanoma.

Clinical Trial Description

Treatment of patients with metastatic ocular melanoma with combination chemotherapy Gemcitabine and Treosulfan versus monotherapy with Treosulfan as first-line chemotherapy. ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00168870
Study type	Interventional
Source	Charite University, Berlin, Germany
Contact	Ulrich Keilholz, MD
Phone	+49-30-8445-3596
Email	ulrich.keilholz@charite.de
Status	Recruiting
Phase	Phase 2
Start date	February 2003

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04364230` - Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma)	Phase 1/Phase 2
Completed	`NCT01200238` - STA-9090(Ganetespib) in Metastatic Ocular Melanoma	Phase 2
Completed	`NCT02858869` - Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases	Phase 1
Completed	`NCT01355120` - THE IPI - Trial in Advanced Melanoma: Melanoma Patients With Advanced Disease	Phase 2
Recruiting	`NCT05524935` - Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma	Phase 2
Recruiting	`NCT05628883` - Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma	Phase 1
Active, not recruiting	`NCT05187884` - Neoadjuvant/Adjuvant Trial of Darovasertib in Ocular Melanoma	Phase 2
Recruiting	`NCT02909517` - The Role of Inflammation in Ocular Tumours
Withdrawn	`NCT00621439` - Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye	N/A
Terminated	`NCT00346372` - Optical Coherence Tomography of Retinal Abnormalities Associated With Choroidal Nevus, Choroidal Melanoma and Choroidal Melanoma Treated With Iodine-125 Brachytherapy
Recruiting	`NCT03172299` - Prevention of Neovascular Glaucoma by Intravitreal Injections of Anti-VEGF in Patients Treated With Proton Therapy for a Large Choroidal Melanoma	Phase 3
Not yet recruiting	`NCT06432660` - Eye Plaque Brachytherapy for Ocular Melanoma
Completed	`NCT01893099` - Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma	Phase 1
Completed	`NCT00351728` - Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone	N/A
Active, not recruiting	`NCT03528408` - Study of Adjuvant Ipilimumab and Nivolumab in Subjects With High-risk Ocular Melanoma	Phase 2
Completed	`NCT03052127` - Study in Subjects With Small Primary Choroidal Melanoma	Phase 1/Phase 2
Withdrawn	`NCT01930968` - Definity for Ultrasound of Intraocular Tumors
Completed	`NCT02519322` - Neoadjuvant and Adjuvant Checkpoint Blockade	Phase 2
Recruiting	`NCT06007690` - A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma	Phase 3
Active, not recruiting	`NCT04417530` - Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma	Phase 2